Membranous nephropathy.

C Ponticelli, P Passerini - Treatment of Primary …, 1997 - books.google.com
Primary membranous nephropathy (MN) is an auto-immune glomerular disease which is
characterized histologically by uniform thickening of the glomerular capillary due to the …

Therapies for membranous nephropathy: a tale from the old and new millennia

F Scolari, F Alberici, F Mescia, E Delbarba… - Frontiers in …, 2022 - frontiersin.org
Primary Membranous Nephropathy (PMN) is the most frequent cause of nephrotic syndrome
in adults. If untreated, PMN can lead to end-stage renal disease; moreover, affected patients …

Low-dose Rituximab therapy in resistant idiopathic membranous nephropathy: single-center experience

S Bagchi, AK Subbiah, D Bhowmik… - Clinical kidney …, 2018 - academic.oup.com
Background Persistent significant proteinuria has been associated with increased risk of
progression to end-stage kidney disease in patients with idiopathic membranous …

Tacrolimus prevents TWEAK-induced PLA2R expression in cultured human podocytes

L Cuarental, L Valiño-Rivas, L Mendonça… - Journal of Clinical …, 2020 - mdpi.com
Primary membranous nephropathy is usually caused by antibodies against the podocyte
antigen membrane M-type phospholipase A2 receptor (PLA2R). The treatment of …

Comparison of tacrolimus with or without prednisone therapy in primary membranous nephropathy: a retrospective clinical study

X Zhang, J Dou, G Gao, X Sheng, Y Shen, Y Feng… - Scientific Reports, 2024 - nature.com
Previous studies showed tacrolimus monotherapy and dual therapy with tacrolimus and
prednisone as effective treatment modalities in managing membranous nephropathy …

Effect of CYP3 A4, CYP3 A5 and ABCB1 gene polymorphisms on the clinical efficacy of tacrolimus in the treatment of nephrotic syndrome

M Li, M Xu, W Liu, X Gao - BMC Pharmacology and Toxicology, 2018 - Springer
Background The efficacy of tacrolimus (TAC) is variable in the treatment of nephrotic
syndrome (NS), which might be related to genetic variation among patients. Therefore, we …

Efficacy and safety of tacrolimus‐based treatment for nephrotic idiopathic membranous nephropathy in young adults: A retrospective study

XJ Zhang, CF Ji, JZ Yuan, L Wang… - … Journal of Medical …, 2019 - Wiley Online Library
In China, the prevalence of idiopathic membranous nephropathy (IMN) is increasing with a
younger age of onset. From January 2012 to October 2018, biopsy‐proven nephrotic IMN …

[PDF][PDF] Membranous nephropathy: current understanding in the light of new advances

H Özer, I Baloğlu, FC Fervenza… - Turkish Journal of …, 2023 - turkjnephrol.org
Membranous nephropathy is the most common cause of primary nephrotic syndrome in
adults. The most important mechanism in its pathogenesis is loss of immune tolerance. New …

[HTML][HTML] Profile and primary treatment outcomes in membranous nephropathy

MKH Kumar, J Sandhu, JS Sandhu - Saudi Medical Journal, 2022 - ncbi.nlm.nih.gov
Objectives: To assess the clinical profile and primary treatment response and outcomes in
idiopathic membranous nephropathy (IMN) patients. Methods: This study was carried out …

Acute kidney injury following exposure to calcineurin inhibitors in a patient with idiopathic membranous nephropathy

M Goździk, A Płuciennik, A Zawiasa-Bryszewska… - Drug safety-case …, 2019 - Springer
Membranous nephropathy (MN) is one of the most common causes of nephrotic syndrome
in non-diabetic adult patients; 75% of adult patients with MN suffer from primary idiopathic …